BEAM
$38.28
Beam Therapeutics
$2.59
7.26%
BEAM
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.57)
Revenue:  $0.01 Mil
Wednesday
Nov 11
6:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BEAM reports earnings?
Beat
Meet
Miss

Where is BEAM's stock price going from here?
Up
Flat
Down
Stock chart of BEAM
Analysts
Summary of analysts' recommendations for BEAM
Score
Grade
Pivots
Resistance
$44.65
$41.77
$38.73

$35.85

Support
$32.81
$29.93
$26.89
Tweet
Growth
Description
Beam Therapeutics Inc. is a biotechnology company. It engages in developing precision genetic medicines through base editing. Beam Therapeutics Inc. is based in Cambridge, Massachusetts.